Antiplatelet drugs

Br J Pharmacol. 2006 Jan;147 Suppl 1(Suppl 1):S241-51. doi: 10.1038/sj.bjp.0706401.

Authors

Gustav Born¹, Carlo Patrono

Affiliation

¹ William Harvey Research Institute, St Bartholomew's and the Royal London School of Medicine and Dentistry, University of London, London.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Aspirin / pharmacology
Aspirin / therapeutic use
Clinical Trials as Topic
Dipyridamole / pharmacology
Dipyridamole / therapeutic use
Humans
Platelet Aggregation
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / pharmacology
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Function Tests
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
Pyridines / pharmacology
Pyridines / therapeutic use
Thrombosis / blood
Thrombosis / prevention & control

Substances

Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Pyridines
Dipyridamole
Aspirin